$1.88 Billion is the total value of Boxer Capital, LLC's 73 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 20.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Buy | Mirati Therapeutics Inc | $139,454,726 | +192890.2% | 3,201,440 | +60.1% | 7.42% | +121.5% |
| RVMD | Revolution Medicines Inc | $129,660,428 | +103376.7% | 4,684,264 | 0.0% | 6.90% | +18.8% | |
| BGNE | BeiGene Ltdsponsored adr | $89,935,000 | +100780.5% | 500,000 | 0.0% | 4.79% | +15.8% | |
| Tyra Biosciences Inc | $88,793,903 | +80757.0% | 6,448,359 | 0.0% | 4.73% | -7.2% | ||
| AKRO | Akero Therapeutics Inc | $84,809,155 | +108231.1% | 1,676,733 | 0.0% | 4.52% | +24.3% | |
| Tango Therapeutics Inc | $80,212,209 | +339063.7% | 7,123,642 | 0.0% | 4.27% | +289.2% | ||
| SWTX | Springworks Therapeutics Inc | $79,106,028 | +88076.8% | 3,421,541 | 0.0% | 4.21% | +1.2% | |
| SRPT | Sarepta Therapeutics Inc | $72,732,000 | +105750.5% | 600,000 | 0.0% | 3.87% | +21.5% | |
| APLS | Buy | Apellis Pharmaceuticals Inc | $65,657,040 | +45630.5% | 1,726,000 | +9.5% | 3.50% | -47.5% |
| CYTK | Cytokinetics Inc | $61,866,000 | +90212.7% | 2,100,000 | 0.0% | 3.29% | +3.7% | |
| IDYA | Ideaya Biosciences Inc | $59,431,868 | +114708.7% | 2,202,812 | 0.0% | 3.16% | +31.8% | |
| Nuvalent Inc | $55,632,526 | +108910.7% | 1,210,192 | 0.0% | 2.96% | +25.1% | ||
| IMGN | ImmunoGen Inc | $46,991,070 | +84001.9% | 2,961,000 | 0.0% | 2.50% | -3.4% | |
| MRUS | Merus N V | $44,802,000 | +89455.6% | 1,900,000 | 0.0% | 2.38% | +2.8% | |
| KRTX | Karuna Therapeutics Inc | $42,272,500 | +77874.8% | 250,000 | 0.0% | 2.25% | -10.5% | |
| ARGX | Buy | Argenx SEsponsored adr | $41,788,550 | +142864.6% | 85,000 | +13.3% | 2.22% | +64.1% |
| LEGN | Legend Biotech Corpsponsored ads | $40,302,000 | +97205.5% | 600,000 | 0.0% | 2.14% | +11.7% | |
| Amylyx Pharmaceuticals Inc | $38,158,040 | +84786.2% | 2,084,000 | 0.0% | 2.03% | -2.6% | ||
| XBI | New | SPDR Ser Trs&p biotech | $36,510,000 | – | 500,000 | +100.0% | 1.94% | – |
| PRTA | Buy | Prothena Corp PLC | $30,156,250 | +147118.6% | 625,000 | +108.3% | 1.60% | +68.9% |
| RCKT | Rocket Pharmaceuticals Inc | $30,039,385 | +103021.8% | 1,466,051 | 0.0% | 1.60% | +18.4% | |
| Ventyx Biosciences Inc | $29,520,500 | +105784.1% | 850,000 | 0.0% | 1.57% | +21.5% | ||
| IMVT | New | Immunovant Inc | $28,792,500 | – | 750,000 | +100.0% | 1.53% | – |
| RCUS | Arcus Biosciences Inc | $28,759,490 | +88279.2% | 1,602,200 | 0.0% | 1.53% | +1.5% | |
| FOLD | Amicus Therapeutics Inc | $28,272,000 | +96715.3% | 2,325,000 | 0.0% | 1.50% | +11.2% | |
| AXSM | Axsome Therapeutics Inc | $27,956,000 | +97158.6% | 400,000 | 0.0% | 1.49% | +11.6% | |
| EXEL | Exelixis Inc | $25,127,500 | +114235.4% | 1,150,000 | 0.0% | 1.34% | +31.3% | |
| ANAB | AnaptysBio Inc | $23,348,000 | +88198.9% | 1,300,000 | 0.0% | 1.24% | +1.4% | |
| SAGE | Sage Therapeutics Inc | $22,514,520 | +43668.5% | 1,094,000 | 0.0% | 1.20% | -49.7% | |
| VKTX | Viking Therapeutics Inc | $22,140,000 | +68191.2% | 2,000,000 | 0.0% | 1.18% | -21.6% | |
| XENE | Xenon Pharmaceuticals Inc | $20,496,000 | +88627.3% | 600,000 | 0.0% | 1.09% | +1.9% | |
| ITOS | Sell | iTeos Therapeutics Inc | $19,754,435 | +69165.2% | 1,804,058 | -16.2% | 1.05% | -20.5% |
| PMVP | PMV Pharmaceuticals Inc | $19,425,701 | +97984.8% | 3,163,795 | 0.0% | 1.03% | +12.6% | |
| IOVA | Iovance Biotherapeutics Inc | $16,858,355 | +64531.0% | 3,705,133 | 0.0% | 0.90% | -25.9% | |
| PNT | Point Biopharma Global Inc | $16,675,000 | +73520.3% | 2,500,000 | 0.0% | 0.89% | -15.4% | |
| KALV | Kalvista Pharmaceuticals Inc | $15,889,500 | +106900.0% | 1,650,000 | 0.0% | 0.85% | +22.8% | |
| RLAY | Relay Therapeutics Inc | $15,298,900 | +66859.5% | 1,819,132 | 0.0% | 0.81% | -23.2% | |
| MDGL | Madrigal Pharmaceuticals Inc | $14,604,000 | +63120.8% | 100,000 | 0.0% | 0.78% | -27.5% | |
| DAWN | Day One Biopharmaceuticals I | $14,600,601 | +102663.2% | 1,189,943 | 0.0% | 0.78% | +17.9% | |
| ORIC | Oric Pharmaceuticals Inc | $10,482,055 | +77862.5% | 1,732,571 | 0.0% | 0.56% | -10.6% | |
| CGEM | Cullinan Oncology Inc | $9,720,442 | +84008.7% | 1,074,082 | 0.0% | 0.52% | -3.5% | |
| NRIX | Nurix Therapeutics Inc | $9,627,651 | +78576.6% | 1,224,892 | 0.0% | 0.51% | -9.7% | |
| ABOS | New | Acumen Pharmaceuticals Inc | $9,158,979 | – | 2,206,983 | +100.0% | 0.49% | – |
| ZNTL | Zentalis Pharmaceuticals Inc | $9,027,000 | +71006.7% | 450,000 | 0.0% | 0.48% | -18.3% | |
| ASND | Ascendis Pharma A/Ssponsored adr | $8,895,800 | +104815.7% | 95,000 | 0.0% | 0.47% | +20.6% | |
| Sell | Enliven Therapeutics Inc | $8,825,152 | +60746.3% | 646,058 | -9.1% | 0.47% | -30.2% | |
| PRLD | Prelude Therapeutics Inc | $7,709,606 | +68564.1% | 2,495,018 | 0.0% | 0.41% | -21.3% | |
| RNA | Avidity Biosciences Inc | $7,154,066 | +57427.1% | 1,121,327 | 0.0% | 0.38% | -34.0% | |
| GERN | Geron Corp | $6,360,000 | +65943.6% | 3,000,000 | 0.0% | 0.34% | -24.2% | |
| GOSS | Buy | Gossamer Bio Inc | $5,411,285 | +135047.0% | 6,497,700 | +94.7% | 0.29% | +54.8% |
| COGT | Cogent Biosciences Inc | $5,118,750 | +82248.0% | 525,000 | 0.0% | 0.27% | -5.6% | |
| CNTA | Sell | Centessa Pharmaceuticals PLCsponsored ads | $4,986,481 | +64283.2% | 770,708 | -38.4% | 0.26% | -26.2% |
| RAPT | Rapt Therapeutics Inc | $4,986,000 | +88777.0% | 300,000 | 0.0% | 0.26% | +1.9% | |
| Sell | Third Harmonic Bio Inc | $3,325,465 | +121090.4% | 520,417 | -8.8% | 0.18% | +39.4% | |
| MRSN | Buy | Mersana Therapeutics Inc | $2,540,000 | +77103.6% | 2,000,000 | +100.0% | 0.14% | -11.8% |
| EQRx Inc | $2,220,000 | +119254.8% | 1,000,000 | 0.0% | 0.12% | +37.2% | ||
| Sell | Orchestra Biomed Hldgs Inc | $2,077,043 | +118588.2% | 238,193 | -4.7% | 0.11% | +37.0% | |
| 2Seventy Bio Inc | $1,802,557 | +38631.3% | 459,836 | 0.0% | 0.10% | -55.6% | ||
| BDTX | Sell | Black Diamond Therapeutics I | $1,452,220 | +14172.4% | 506,000 | -74.9% | 0.08% | -83.7% |
| DBVT | Sell | DBV Technologies S Asponsored adr | $1,339,736 | +48529.3% | 985,100 | -32.1% | 0.07% | -44.5% |
| BCAB | BioAtla Inc | $1,166,790 | +56567.8% | 686,347 | 0.0% | 0.06% | -34.7% | |
| KOD | New | Kodiak Sciences Inc | $1,080,000 | – | 600,000 | +100.0% | 0.06% | – |
| FATE | Fate Therapeutics Inc | $1,060,000 | +44437.8% | 500,000 | 0.0% | 0.06% | -49.1% | |
| RAIN | Rain Oncology Inc | $992,976 | +71698.7% | 1,152,212 | 0.0% | 0.05% | -17.2% | |
| MIST | Sell | Milestone Pharmaceuticals In | $957,922 | +47988.5% | 309,007 | -55.8% | 0.05% | -44.6% |
| VRCA | New | Verrica Pharmaceuticals Inc | $648,620 | – | 166,955 | +100.0% | 0.04% | – |
| BCEL | Atreca Inc | $574,809 | +26536.2% | 2,202,333 | 0.0% | 0.03% | -69.0% | |
| NGM | NGM Biopharmaceuticals Inc | $535,000 | +41212.7% | 500,000 | 0.0% | 0.03% | -53.3% | |
| Sell | Theseus Pharmaceuticals Inc | $403,500 | +12254.6% | 150,000 | -57.1% | 0.02% | -86.1% | |
| TARA | Protara Therapeutics Inc | $349,409 | +69781.8% | 209,227 | 0.0% | 0.02% | -17.4% | |
| ZIOP | Sell | Alaunos Therapeutics Inc | $144,980 | +18851.6% | 1,100,000 | -26.7% | 0.01% | -77.1% |
| NUVBWS | Nuvation Bio Inc*w exp 07/07/202 | $26,667 | +60506.8% | 266,666 | 0.0% | 0.00% | -50.0% | |
| Surrozen Inc*w exp 08/01/203 | $2,747 | +68575.0% | 66,666 | 0.0% | 0.00% | – | ||
| Exit | Bellicum Pharmaceuticals Inc | $0 | – | -450,000 | -100.0% | -0.01% | – | |
| VERU | Exit | Veru Inc | $0 | – | -347,300 | -100.0% | -0.02% | – |
| MEIP | Exit | MEI Pharma Inc | $0 | – | -145,654 | -100.0% | -0.04% | – |
| KNTE | Exit | Kinnate Biopharma Inc | $0 | – | -491,000 | -100.0% | -0.07% | – |
| MREO | Exit | Mereo Biopharma Group PLCspon ads | $0 | – | -2,250,000 | -100.0% | -0.14% | – |
| SELB | Exit | Selecta Biosciences Inc | $0 | – | -3,284,072 | -100.0% | -0.17% | – |
| Exit | Disc Medicine Inc | $0 | – | -130,000 | -100.0% | -0.27% | – | |
| CABA | Exit | Cabaletta Bio Inc | $0 | – | -540,000 | -100.0% | -0.32% | – |
| ISEE | Exit | Iveric Bio Inc | $0 | – | -825,000 | -100.0% | -1.50% | – |
| ETNB | Exit | 89Bio Inc | $0 | – | -2,100,000 | -100.0% | -1.85% | – |
| RETA | Exit | Reata Pharmaceuticals Inccl a | $0 | – | -1,430,004 | -100.0% | -6.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.